TheraRadar
← Back
Data updated: Mar 29, 2026

LGM PHARMA

MetabolicImmunologyCardiovascular
Generics

LGM PHARMA is a generic drug manufacturer focused on Metabolic, Immunology, Cardiovascular.

2001
Since
12
Drugs
-
Trials
64
Approved (2yr)

Key Drugs

HYDROCODONE BITARTRATE AND ASPIRIN
aspirin
Pain
1 indications · 2021

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
GLYCOPYRROLATE 2026-01-19
Labeling
GLYCOPYRROLATE 2026-01-19
Labeling
HYDROCODONE BITARTRATE AND ASPIRIN 2026-01-02
Labeling
GLYCOPYRROLATE 2025-12-23
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 2025-12-22
Labeling
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 2025-12-22
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 33%
1 drugs
Immunology 33%
1 drugs
Cardiovascular 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Merck big-pharma
Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Cardiovascular, Metabolic
AstraZeneca big-pharma
Cardiovascular, Metabolic, Immunology
Boehringer Ingelheim big-pharma
Metabolic, Immunology, Cardiovascular
Novartis big-pharma
Cardiovascular, Immunology